These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1340 related articles for article (PubMed ID: 12816671)

  • 21. Elevated levels of tetraploid cervical cells in human papillomavirus-positive Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance.
    Olaharski AJ; Eastmond DA
    Cancer; 2004 Jun; 102(3):192-9. PubMed ID: 15211479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.
    Ahdieh L; Klein RS; Burk R; Cu-Uvin S; Schuman P; Duerr A; Safaeian M; Astemborski J; Daniel R; Shah K
    J Infect Dis; 2001 Sep; 184(6):682-90. PubMed ID: 11517428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diagnosis of human papillomavirus: comparison between cervical and vaginal sampling.
    Finan RR; Irani-Hakime N; Tamim H; Almawi WY
    Infect Dis Obstet Gynecol; 2001; 9(2):119-22. PubMed ID: 11495553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
    Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
    Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
    J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.
    Rousseau MC; Pereira JS; Prado JC; Villa LL; Rohan TE; Franco EL
    J Infect Dis; 2001 Dec; 184(12):1508-17. PubMed ID: 11740725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
    Harnish DG; Belland LM; Scheid EE; Rohan TE
    Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women.
    Koshiol J; Schroeder J; Jamieson DJ; Marshall SW; Duerr A; Heilig CM; Shah KV; Klein RS; Cu-Uvin S; Schuman P; Celentano D; Smith JS
    Am J Epidemiol; 2006 Jul; 164(2):176-83. PubMed ID: 16775041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of 14 human papillomavirus genotypes in cervical samples in women from a central-southern area of Italy showing different Pap test results.
    Zappacosta B; Romano L; Guerriero M; Graziano M; Vitrani A; De Ninno M; Carbone A
    New Microbiol; 2009 Oct; 32(4):351-8. PubMed ID: 20128441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women.
    Chabaud M; Le Cann P; Mayelo V; Leboulleux D; Diallo AS; Enogat N; Afoutou JM; Anthonioz P; Coll-Seck AM; Coursaget P
    J Med Virol; 1996 Aug; 49(4):259-63. PubMed ID: 8877756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor.
    Zuna RE; Moore W; Dunn ST
    Mod Pathol; 2001 Mar; 14(3):147-51. PubMed ID: 11266518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and typing of human papillomavirus in biopsy and cytological specimens by polymerase chain reaction and restriction enzyme analysis: a method suitable for semiautomation.
    Adams V; Moll C; Schmid M; Rodrigues C; Moos R; Briner J
    J Med Virol; 1996 Feb; 48(2):161-70. PubMed ID: 8835350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history of type-specific human papillomavirus infections in female university students.
    Richardson H; Kelsall G; Tellier P; Voyer H; Abrahamowicz M; Ferenczy A; Coutlée F; Franco EL
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):485-90. PubMed ID: 12814991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
    J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
    Apgar BS; Brotzman G
    Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.
    Franco EL; Villa LL; Sobrinho JP; Prado JM; Rousseau MC; Désy M; Rohan TE
    J Infect Dis; 1999 Nov; 180(5):1415-23. PubMed ID: 10515798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative image analysis of oesophageal squamous cell carcinoma from the high-incidence area of China, with special reference to tumour progression and papillomavirus (HPV) involvement.
    Tripodi S; Chang F; Syrjänen S; Shen Q; Cintorino M; Alia L; Santopietro R; Tosi P; Syrjänen K
    Anticancer Res; 2000; 20(5C):3855-62. PubMed ID: 11268467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing.
    Andersson S; Rylander E; Larson B; Sigurdardottir S; Backlund I; Sällström J; Wilander E
    Oncol Rep; 2003; 10(1):175-9. PubMed ID: 12469166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test.
    Papachristou E; Sypsa V; Paraskevis D; Gkekas A; Politi E; Nicolaidou E; Anifantis I; Psichogiou M; Tsitsika A; Hadjivassiliou M; Petrikkos G; Katsambas A; Creatsas G; Hatzakis A
    J Med Virol; 2009 Dec; 81(12):2059-65. PubMed ID: 19856480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy.
    Garbuglia AR; Piselli P; Lapa D; Sias C; Del Nonno F; Baiocchini A; Cimaglia C; Agresta A; Capobianchi MR
    J Clin Virol; 2012 Jun; 54(2):141-6. PubMed ID: 22437054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.